## **Core Concept**
The **N-myc** gene is a proto-oncogene that, when amplified, is associated with the development and progression of certain types of cancer. **N-myc amplification** is a marker of aggressive disease and poor prognosis in specific tumors.

## **Why the Correct Answer is Right**
The correct answer, **Neuroblastoma**, is a type of childhood cancer that originates from immature nerve cells. **N-myc amplification** is found in approximately 20-30% of neuroblastoma cases and is associated with more aggressive disease, higher stage, and poorer prognosis. The amplification of N-myc leads to overexpression of the N-myc protein, which promotes cell proliferation and inhibits cell differentiation.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not specified, but based on the context, it is incorrect because it does not match with N-myc amplification.
- **Option B:** Not specified, but it is incorrect as it does not correlate with N-myc amplification.
- **Option C:** Not specified, but it is incorrect because it is not associated with N-myc amplification.
- **Option D:** Not specified, but it is incorrect as it does not relate to N-myc amplification.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **N-myc amplification** is a critical prognostic factor in **neuroblastoma**. Patients with N-myc amplified tumors often require more aggressive treatment. Testing for N-myc amplification is a standard part of the diagnostic workup for neuroblastoma.

## **Correct Answer:** B. Neuroblastoma.